| SC 13G/A | 2024-02-14 | RA CAPITAL MANAGEMENT, L.P. | Vaxcyte, Inc. | 9,685,079 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Vaxcyte, Inc. | 8,452,371 | 8.9% | EDGAR |
| SC 13G/A | 2024-02-13 | JANUS HENDERSON GROUP PLC | Vaxcyte, Inc. | 6,981,376 | 7.3% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | Vaxcyte, Inc. | 14,213,365 | 14.9% | EDGAR |
| SC 13G/A | 2024-01-25 | BlackRock Inc. | Vaxcyte, Inc. | 8,575,238 | 9.0% | EDGAR |
| SC 13G/A | 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. | Vaxcyte, Inc. | 8,153,559 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-10 | Carlyle Group Inc. | Vaxcyte, Inc. | 2,070,724 | 2.6% | EDGAR |
| SC 13G/A | 2023-02-10 | JANUS HENDERSON GROUP PLC | Vaxcyte, Inc. | 5,974,139 | 7.6% | EDGAR |
| SC 13G/A | 2023-02-10 | TPG GP A, LLC | Vaxcyte, Inc. | 1,190,336 | 1.5% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | Vaxcyte, Inc. | 10,169,281 | 12.9% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Vaxcyte, Inc. | 6,613,666 | 8.4% | EDGAR |
| SC 13G | 2023-02-03 | BlackRock Inc. | Vaxcyte, Inc. | 5,105,370 | 6.5% | EDGAR |
| SC 13G/A | 2022-03-09 | BlackRock Inc. | Vaxcyte, Inc. | 2,789,007 | 5.0% | EDGAR |
| SC 13G/A | 2022-02-15 | Longitude Venture Partners II, L.P. | Vaxcyte, Inc. | 1,606,350 | 3.0% | EDGAR |
| SC 13G/A | 2022-02-14 | Abingworth LLP | Vaxcyte, Inc. | 4,183,716 | 7.9% | EDGAR |
| SC 13G/A | 2022-02-14 | ROCHE FINANCE LTD | Vaxcyte, Inc. | 2,334,113 | 4.4% | EDGAR |
| SC 13G/A | 2022-02-10 | JANUS HENDERSON GROUP PLC | Vaxcyte, Inc. | 4,246,664 | 8.0% | EDGAR |
| SC 13G | 2022-02-10 | VANGUARD GROUP INC | Vaxcyte, Inc. | 3,134,286 | 5.9% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | Vaxcyte, Inc. | 7,874,350 | 14.9% | EDGAR |
| SC 13G | 2022-02-04 | BlackRock Inc. | Vaxcyte, Inc. | 2,777,047 | 5.3% | EDGAR |